Advanced Antibody Explorers

“We bring
science to life.”

AAX Biotech is committed to advancing next-generation therapies for a range of diseases. With a focus on antibody-based medicines, our proprietary technologies aim to solve key challenges in drug development. Our vision is to establish AAX as a leading, highly competitive partner serving the bio-pharma industry worldwide.

About us

We are a research-driven company focused on enabling and accelerating the development of highly effective antibody-based medicines. By offering innovative solutions to well-recognized challenges in the rapidly expanding biotherapeutics market, we aim to accelerate drug development and improve therapeutic outcomes.

Our Science

Our innovative technologies Seqitope® and Opti-mAb™ address significant hurdles in the generation of novel antibody therapeutics, the fastest growing segment in pharmaceuticals for more than 20 years

Supported by

Christer Nordstedt, Chief Executive Officer, Oblique Therapeutics

“Their Seqitope® technology has provided a level of insight into the interaction between our drug candidates and their target that was previously unattainable using conventional epitope mapping techniques.”

News

.

News .

Contact us.

Get in touch with us for any inquiries – we are happy to talk!

info@aaxbiotech.com